Related Experiment Video
Updated: Aug 9, 2026
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand, antimycin A
K M Kim1, C D Giedt, G Basañez
1Divisions of Basic Sciences and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Abstract:
Apoptosis is an essential physiological process, regulated by the family of Bcl-2-related proteins. However, the molecular mechanism by which Bcl-2 regulates apoptosis still remains elusive. Here we report the functional studies of recombinant human Bcl-2 with the deletion of 22 residues at the C-terminal membrane-anchoring region (rhBcl-2Delta22). Characterization of rhBcl-2Delta22 showed that the recombinant protein is homogeneous and monodisperse in nondenaturing solutions, stable at room temperature in the presence of a metal chelator, and an alpha-helical protein with unfolding of secondary structure at a T(m) of 62.8 degrees C. Optimal membrane pore formation by rhBcl-2Delta22 required negatively charged phospholipids. The existence of a hydrophobic groove in rhBcl-2Delta22 was demonstrated by the fluorescence enhancement of the hydrophobic ANS probe with which a pro-apoptotic Bak BH3 peptide competed. The respiratory inhibitor antimycin A also bound to the hydrophobic groove of rhBcl-2Delta22 with a K(d) of 0.82 microM. The optimal binding conformation of antimycin A was predicted from molecular docking of antimycin A with the hBcl-2 model created by homology modeling. Antimycin A selectively induces apoptosis in cells overexpressing Bcl-2, suggesting that hydrophobic groove-binding compounds may act as selective apoptotic triggers in tumor cells.
Insights
Researchers studied a modified Bcl-2 protein to understand apoptosis regulation. They found a hydrophobic groove that binds compounds like antimycin A, potentially triggering cancer cell death.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Apoptosis is a vital physiological process controlled by Bcl-2 proteins.
- The precise molecular mechanism of Bcl-2 in apoptosis regulation remains unclear.
Purpose of the Study:
- To investigate the functional properties of recombinant human Bcl-2 lacking its C-terminal membrane-anchoring region (rhBcl-2Delta22).
- To elucidate the role of a hydrophobic groove in rhBcl-2Delta22 interactions and its potential for apoptosis induction.
Main Methods:
- Characterization of recombinant rhBcl-2Delta22 protein stability, homogeneity, and secondary structure.
- Assessing membrane pore formation in the presence of negatively charged phospholipids.
- Utilizing ANS fluorescence probe and Bak BH3 peptide competition to identify a hydrophobic groove.
- Investigating the binding of antimycin A to the hydrophobic groove using fluorescence spectroscopy and molecular docking.
Main Results:
- rhBcl-2Delta22 is a stable, alpha-helical protein that forms membrane pores with negatively charged phospholipids.
- A hydrophobic groove in rhBcl-2Delta22 was identified, binding a Bak BH3 peptide and the respiratory inhibitor antimycin A (Kd = 0.82 μM).
- Molecular docking predicted the binding conformation of antimycin A, and it selectively induced apoptosis in Bcl-2 overexpressing cells.
Conclusions:
- The C-terminal deletion of Bcl-2 retains its ability to interact with phospholipids and form pores.
- The identified hydrophobic groove is a key functional site for ligand binding, including antimycin A.
- Compounds targeting this hydrophobic groove may serve as selective apoptosis inducers for cancer therapy.
